Home / Europe / Austria / Life Sciences & Healthcare

Life Sciences & Healthcare


Law firm for Life Sciences & Healthcare in Austria 

The legal issues in health care law—such as those arising from e-health solutions, personalised medicine or cost-cutting restructuring—are increasing in complexity and require the coordination of a variety of specialist areas. Our experts have diverse professional backgrounds and combine specialist know-how with many years of experience in the industry. For example, we assist hospitals, outpatient clinics and group practices to draft contracts for healthcare professionals, also  for operational management of hospitals ("kollegiale Führung"). In addition, we have gained in-depth knowledge about the applicable regulatory requirements from advising pharmaceutical, medical device and biotechnology companies, hospitals and pharmacies, as well as universities and interest groups

We are available to advise you on numerous issues, including:

•    Drafting strategic agreements,
•    Planning a corporate transaction,
•    Employment of healthcare professionals,
•    Implementing compliance requirements, and
•    Enforcement and defence of claims in court.

A strong international network in the Life Sciences & Healthcare field:

The CMS Life Sciences & Healthcare Sector Group consists of a team of over 480 lawyers, patent attorneys, scientists and academics from all over the world. Our clients include the 20 leading global pharmaceutical companies and the 10 leading global medical device companies. Many of our experts worked in the Life Sciences & Healthcare sector before joining CMS and have extensive knowledge of the industry.

Our legal advice in the healthcare sector

We advise our clients in the following specific areas:

•    Pharmaceutical law
•    Medical device law
•    Hospital and pharmacy law
•    Medical professional law
•    Preclinical and clinical studies

•    Reimbursement / market access
•    Licensing, research and development collaborations
•    Advertising and marketing
•    Antitrust and distribution law
•    Anti-corruption criminal law and compliance
•    Data protection
•    Patent, trademark, design and copyright law, protection certificates
•    Customs procedures, product piracy and parallel imports
•    Product liability law
•    Dispute resolution
•    Corporate law, M&A and financing
•    Tax law
•    Labour Law
•    Social security law
•    Contract partner law
•    Public procurement law
•    Plant protection
•    Narcotics law
•    Food Law

Stay up to date

Would you like to receive regular information from us? Sign up for our newsletter (in German) and receive useful information on events or other important legal developments by e-mail.

Get to know our lawyers for Life Sciences & Healthcare here.

Calling the team "pragmatic and hands-on," a client extols its broad expertise and commercial understanding: "What I like about working with CMS is the fact that they can cover a wide range of legal topics when there are overlaps with other areas."

Chambers Europe 2022

Another client emphasises the law firm's client service: "I would particularly like to emphasise that the CMS team is always available for all of my concerns. I was not used to the fast response times and great commitment from my previous legal advisers and I do not want to do without CMS from now on. Based on my experience so far, I am convinced that the team will also support me in future to my absolute satisfaction."

Chambers Europe 2022

Choose area

Medical Law
Medical professional & labour law as key elements of the healthcare industryMedical professional law and labour or service law play a central role in


CMS Life Sci­ence Award 2022
Ver­öf­fent­licht am 29. Novem­ber 2022In Ko­op­er­a­tion mit CMS Reich-Rohr­wig Hainz ver­lieh die Recht­swis­senschaft­liche Fak­ultät der Uni­versität Inns­bruck er­st­mals den „CMS Life Sci­ences Award“ 2022. Der dies­jährige Pre­is­träger Mat­thi­as Rief, Ab­solvent des Doko­trat­skolleg Med­iz­in­recht und Ge­sund­heit­swesen an der Uni­versität Inns­bruck, wurde für seine Dis­ser­ta­tion "Im­planti­erbare Med­iz­in­produkte der Klasse III: Aus­gewählte Haf­tungs­fra­gen vor dem Hin­ter­grund der neuen Med­iz­in­produkte-Ver­or­d­nung (EU)" aus­gezeich­net. CMS Part­ner­in und Life Sci­ence & Health­care Ex­per­tin Gab­ri­ele Staber ver­trat CMS als Jurymit­glied.
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...
Glob­al Life Sci­ences & Health­care For­um 2022: The Life Sci­ences sec­tor...
The open­ing of COP27 has brought an in­tense glob­al fo­cus on cli­mate change and the tower­ing de­mands needed to reach car­bon net zero and to pro­tect the en­vir­on­ment. United Na­tions Gen­er­al Sec­ret­ary Ant­o­nio...
Glob­al Life Sci­ences & Health­care For­um 2022: The leg­al sec­tor has a key...
The United Na­tions has pledged to use its pur­chas­ing fire­power to ac­cel­er­ate sus­tain­ab­il­ity along the health­care sup­ply chan­nel and called on the leg­al sec­tor to sup­port its ef­forts. Law­yers are crit­ic­al...
Skin­teg­rated Cos­me­ceut­ic­als - is Pharma be­com­ing sexy (again?)
Case Study: Skin­tegra, Skin­teg­rity Cos­me­ceut­ic­als are sexy right now.  They’re less reg­u­lated than the phar­ma­ceut­ic­al in­dustry (al­though don’t let that fool you in­to be­liev­ing you can say whatever...
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? 1.1 Medi­cines The primary leg­al source is the Medi­cin­al Products Act (Ar­zneimit­tel­ge­setz – AMG). In ad­di­tion, the...
UPC Rules of Pro­ced­ure go in­to force with judg­ments to be made pub­lic
The entry in­to force of the Rules of Pro­ced­ure is part of the fi­nal pre­par­a­tions for the United Pat­ent Court (UPC), which is cur­rently ex­pec­ted to start work in early 2023. After the bod­ies of the UPC...
Can­nabis law and le­gis­la­tion in Aus­tria
Med­ic­al use Ac­cord­ing to the Ad­dict­ive Drugs Act, only the Aus­tri­an Agency for Health and Food Safety (AGES; su­per­vised by the Aus­tri­an Fed­er­al Min­istry of La­bour, So­cial Af­fairs, Health and Con­sumer...
Phar­ma­ceut­ic­al trade marks - a real pain in the bum?
An EU IPO Case Study: Proc­to­LYSY­AL v PRO­COTOL­IZ­IN Sum­mary I al­ways like to start at the end.  No nasty sur­prises and you know what to ex­pect.  In this case study, the trade marks ‘proc­to­LYSY­AL’...
Leg­al is­sues in the meta­verse / Part 4 - Ex­pec­ted im­pact of the EU Ar­ti­fi­cial...
Part 4 - Ex­pec­ted im­pact of the EU Ar­ti­fi­cial In­tel­li­gence Reg­u­la­tion, the meta­verse as a work­place In our first art­icle, we ex­amined the nature of the meta­verse, the shared vir­tu­al world. The emer­gence...
Leg­al is­sues in the meta­verse / Part 3 - Data pro­tec­tion chal­lenges, the...
Part 3 - Data pro­tec­tion chal­lenges, the im­port­ance of cy­ber­se­cur­ity, ad­vert­ising reg­u­la­tion in the meta­verse In our first art­icle, we ex­amined the nature of the meta­verse, the shared vir­tu­al world...
European Bolar Pro­vi­sions in Aus­tria
1. How is Bolar im­ple­men­ted? Aus­tria has im­ple­men­ted Bolar with a spe­cif­ic pro­vi­sion in Sec­tion 22, Para­graph 1 of the Pat­ent Act 1970 which gov­erns: “(...)The ef­fect of the pat­ent does not ex­tend...